Literature DB >> 13902276

Coagulation defects in patients with cirrhosis of the liver undergoing portasystemic shunts.

C E GROSSI, L M ROUSSELOT, W F PANKE.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; LIVER CIRRHOSIS/surgery; PORTACAVAL ANASTOMOSIS/complications; PORTAL VEINS/surgery

Mesh：

Year:  1962        PMID： 13902276     DOI： 10.1016/0002-9610(62)90387-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  6 in total

1.  ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors:  A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

2.  SPONTANEOUS FIBRINOLYSIS INDUCED BY IN VITRO ADMIXTURE OF HUMAN PLASMA.

Authors:  S GIANNELLI; C E GROSSI; L M ROUSSELOT; J W VASTOLA; S M AYRES
Journal:  Ann Surg       Date:  1965-01       Impact factor: 12.969

3.  BLEEDING IN SURGERY IN RELATION TO LIVER DISEASE.

Authors:  S SHERLOCK; L ALPERT
Journal:  Proc R Soc Med       Date:  1965-04

4.  The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.

Authors:  D Ogston; N B Bennett; C M Ogston
Journal:  J Clin Pathol       Date:  1971-12       Impact factor: 3.411

5.  The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors.

Authors:  S Takaya; O Bronsther; Y Iwaki; K Nakamura; K Abu-Elmagd; A Yagihashi; A J Demetris; M Kobayashi; S Todo; A G Tzakis
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

6.  Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.

Authors:  Y Kang; J H Lewis; A Navalgund; M W Russell; F A Bontempo; L S Niren; T E Starzl
Journal:  Anesthesiology       Date:  1987-06       Impact factor: 7.892
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.